Clinical Research Detail Title Of Study The purpose of this study is to evaluate the efficacy and safety of canagliflozin compared with sitagliptin in patients with type 2 diabetes mellitus who are receiving treatment with metformin and sulphonylurea and have inadequate glycemic (blood sugar) control. Disease Condition Type 2 Diabetes Mellitus Phase of Trial Phase-3 Discipline Diabetology Start date of Trial 1/15/2011 Closing Date of Trial 1/15/2012 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]